BioCryst Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Jun 23 | SellUS$31,920 | A. Sanders | Individual | 4,000 | US$7.98 | |
14 Jun 23 | SellUS$103,443 | Nancy Hutson | Individual | 12,866 | US$8.04 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 10,456 | 0.00507% |
Individual Insiders | 1,889,641 | 0.916% |
Hedge Funds | 13,050,000 | 6.32% |
General Public | 25,952,386 | 12.6% |
Institutions | 165,474,605 | 80.2% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 9.2%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
18,681,370 | US$99.4m | 11.4% | no data | |||
17,763,720 | US$94.5m | 15.4% | no data | |||
13,050,000 | US$69.4m | 13% | 1.0% | |||
12,777,003 | US$68.0m | 22.1% | no data | |||
10,126,176 | US$53.9m | -20.3% | 0.65% | |||
5,718,477 | US$30.4m | 6.63% | 2.21% | |||
4,600,000 | US$24.5m | 46.8% | 1.79% | |||
4,539,525 | US$24.2m | 38.2% | 0.47% | |||
4,260,638 | US$22.7m | 8.94% | no data | |||
3,846,154 | US$20.5m | 0% | 7.43% | |||
3,459,401 | US$18.4m | 36.6% | no data | |||
3,453,908 | US$18.4m | 47.8% | 0.16% | |||
3,270,381 | US$17.4m | 28.2% | 0.47% | |||
2,884,619 | US$15.3m | 0% | 0.01% | |||
2,865,680 | US$15.2m | 83.3% | no data | |||
2,715,849 | US$14.4m | -8.01% | no data | |||
2,351,720 | US$12.5m | 33.9% | 0.03% | |||
2,268,012 | US$12.1m | -4.26% | 0.03% | |||
2,232,242 | US$11.9m | -7.3% | 4.91% | |||
2,216,612 | US$11.8m | 92.4% | no data | |||
2,151,545 | US$11.4m | -2.08% | 0.65% | |||
1,971,586 | US$10.5m | 383% | 0.03% | |||
1,846,766 | US$9.8m | -0.32% | no data | |||
1,844,055 | US$9.8m | 0% | 0.01% | |||
1,754,980 | US$9.3m | 769% | 0.01% |